Rockefeller Capital Management
IRMD icon

Rockefeller Capital Management’s iRadimed IRMD Stock Holding History

Rockefeller Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14K Buy
145
+20
+16% +$2K ﹤0.01% 3857
2025
Q4 		$12.2K Buy
+125
New +$10.7K ﹤0.01% 3716

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rockefeller Capital Management's IRMD Position: Q1 2026 in Review

Rockefeller Capital Management increased its iRadimed (IRMD) stake by 16% in Q1 2026, buying an estimated $2K and bringing the position to 145 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3857.

Rockefeller Capital Management first reported a position in IRMD in Q4 2025 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Rockefeller Capital Management held 145 shares of iRadimed worth $14K as of Q1 2026.
  • Rockefeller Capital Management bought 20 iRadimed shares in Q1 2026, an estimated $2K.
  • iRadimed made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3857 holding.
  • Rockefeller Capital Management first reported a position in iRadimed in Q4 2025 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.